Compare Novartis AG (NVS) vs Upstart Holdings Inc (UPST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Upstart Holdings Inc — how do they compare? Novartis AG trades at $152.33 (market cap $295.37B), while Upstart Holdings Inc trades at $30.01 (market cap $2.91B). The key difference: Novartis AG is far larger — about 101.5× Upstart Holdings Inc's market cap, and Novartis AG pays a 3.07% dividend while Upstart Holdings Inc pays none. Which is the better fit depends on your goals.
| NVS | UPST | |
|---|---|---|
Market Cap | $295.37B | $2.91B |
Sector | Health | Financials |
52-Week High | $168.62 | $73.76 |
52-Week Low | $119.31 | $24.22 |
Enterprise Value | $336.69B | — |
Dividend Yield | 3.07% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Upstart Holdings Inc
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.
Read more on UPST →
